Annual CFO
-$2.08 M
+$175.20 K+7.78%
31 December 2022
Summary:
Serina Therapeutics annual cash flow from operations is currently -$2.08 million, with the most recent change of +$175.20 thousand (+7.78%) on 31 December 2022. During the last 3 years, it has risen by +$175.20 thousand (+7.78%). SER annual CFO is now at all-time high.SER Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.96 M
+$5.05 M+63.02%
30 September 2024
Summary:
Serina Therapeutics quarterly cash flow from operations is currently -$2.96 million, with the most recent change of +$5.05 million (+63.02%) on 30 September 2024. Over the past year, it has dropped by -$1.94 million (-189.26%). SER quarterly CFO is now -317.77% below its all-time high of -$709.00 thousand, reached on 31 March 2023.SER Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$12.55 M
-$1.94 M-18.27%
30 September 2024
Summary:
Serina Therapeutics TTM cash flow from operations is currently -$12.55 million, with the most recent change of -$1.94 million (-18.27%) on 30 September 2024. Over the past year, it has dropped by -$10.81 million (-624.06%). SER TTM CFO is now -1669.82% below its all-time high of -$709.00 thousand, reached on 31 March 2023.SER TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SER Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -189.3% | -624.1% |
| 3 y3 years | +7.8% | - | - |
| 5 y5 years | - | - | - |
SER Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +7.8% | -317.8% | +63.0% | -1669.8% | at low |
| 5 y | 5 years | at high | +7.8% | -317.8% | +63.0% | -1669.8% | at low |
| alltime | all time | at high | +7.8% | -317.8% | +63.0% | -1669.8% | at low |
Serina Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.96 M(-63.0%) | -$12.55 M(+18.3%) |
| June 2024 | - | -$8.01 M(+407.9%) | -$10.61 M(+307.9%) |
| Mar 2024 | - | -$1.58 M(+54.0%) | -$2.60 M(+50.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.02 M(+44.4%) | -$1.73 M(+144.4%) |
| Mar 2023 | - | -$709.00 K | -$709.00 K |
| Dec 2022 | -$2.08 M(-7.8%) | - | - |
| Dec 2021 | -$2.25 M | - | - |
FAQ
- What is Serina Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Serina Therapeutics?
- What is Serina Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Serina Therapeutics?
- What is Serina Therapeutics quarterly CFO year-on-year change?
- What is Serina Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Serina Therapeutics?
- What is Serina Therapeutics TTM CFO year-on-year change?
What is Serina Therapeutics annual cash flow from operations?
The current annual CFO of SER is -$2.08 M
What is the all time high annual CFO for Serina Therapeutics?
Serina Therapeutics all-time high annual cash flow from operations is -$2.08 M
What is Serina Therapeutics quarterly cash flow from operations?
The current quarterly CFO of SER is -$2.96 M
What is the all time high quarterly CFO for Serina Therapeutics?
Serina Therapeutics all-time high quarterly cash flow from operations is -$709.00 K
What is Serina Therapeutics quarterly CFO year-on-year change?
Over the past year, SER quarterly cash flow from operations has changed by -$1.94 M (-189.26%)
What is Serina Therapeutics TTM cash flow from operations?
The current TTM CFO of SER is -$12.55 M
What is the all time high TTM CFO for Serina Therapeutics?
Serina Therapeutics all-time high TTM cash flow from operations is -$709.00 K
What is Serina Therapeutics TTM CFO year-on-year change?
Over the past year, SER TTM cash flow from operations has changed by -$10.81 M (-624.06%)